Transient elastography for the diagnosis of liver fibrosis

Expert Review of Medical Devices

Volumn 7, Issue 6, 2010, Pages 811-823

  De Lédinghen, Victor ^a   Vergniol, Julien ^a  

^a HAUT LÉVÊQUE HOSPITAL   (France)

Author keywords

cirrhosis; FibroScan; fibrosis; hepatitis B; hepatitis C; liver stiffness; transient elastography

Indexed keywords

CIRRHOSIS; FIBROSCAN; FIBROSIS; HEPATITIS B; HEPATITIS C; LIVER STIFFNESS; TRANSIENT ELASTOGRAPHY;

DIAGNOSIS; STIFFNESS;

LIVER;

IRON; METHOTREXATE;

ALCOHOL LIVER DISEASE; AREA UNDER THE CURVE; BILIARY TRACT DRAINAGE; CHRONIC LIVER DISEASE; CROHN DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; ECHOGRAPHY; ELASTOGRAPHY; HEMOCHROMATOSIS; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAHEPATIC CHOLESTASIS; IRON OVERLOAD; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER TRANSPLANTATION; MEDICAL ASSESSMENT; MIXED INFECTION; NON INVASIVE MEASUREMENT; NONALCOHOLIC FATTY LIVER; NORMAL VALUE; PORTAL HYPERTENSION; PROGNOSIS; PSORIASIS; RECEIVER OPERATING CHARACTERISTIC; RECURRENT INFECTION; REPRODUCIBILITY; REVIEW; SENSITIVITY AND SPECIFICITY; TRANSIENT ELASTOGRAPHY;

ELASTICITY IMAGING TECHNIQUES; EQUIPMENT DESIGN; EQUIPMENT FAILURE ANALYSIS; FORECASTING; HUMANS; IMAGE ENHANCEMENT; LIVER CIRRHOSIS;

HEPATITIS C VIRUS;

EID: 78149376562     PISSN: 17434440     EISSN: 17452422     Source Type: Journal    
DOI: 10.1586/erd.10.46     Document Type: Review

References (77)

1. Regev A, Berho M, Jeffers LJ et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am. J. Gastroenterol. 97(10), 2614-2618 (2002).
2. Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 38(6), 1449-1457 (2003).
3. The French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 20(1 Pt 1), 15-20 (1994).
4. Sandrin L, Tanter M, Gennisson JL et al. Shear elasticity probe for soft tissues with 1-D transient elastography. IEEE Trans Ultrason Ferroelectr. Freq. Control 49(4), 436-446 (2002).
5. Sandrin L, Fourquet B, Hasquenoph JM et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med. Biol. 29(12), 1705-1713 (2003).
6. Lucidarme D, Foucher J, Le Bail B et al. Factors of accuracy of transient elastography (fibroscan) for the diagnosis of liver fibrosis in chronic hepatitis C. Hepatology 49(4), 1083-1089 (2009).
7. Foucher J, Castera L, Bernard PH et al. Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations. Eur. J. Gastroenterol. Hepatol. 18(4), 411-412 (2006).
8. Castera L, Foucher J, Bernard PH et al. Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations. Hepatology 51(3), 828-835 (2010).
9. Fraquelli M, Rigamonti C, Casazza G et al. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut 56(7), 968-973 (2007).
10. Boursier J, Konate A, Gorea G et al.Reproducibility of liver stiffness measurement by ultrasonographic elastometry. Clin. Gastroenterol. Hepatol. 6(11), 1263-1269 (2008).
11. Kettaneh A, Marcellin P, Douvin C et al. Features associated with success rate and performance of fibroscan measurements for the diagnosis of cirrhosis in HCV patients: a prospective study of 935 patients. J. Hepatol. 46(4), 628-634 (2007).
12. Boursier J, Konate A, Guilluy M et al. Learning curve and interobserver reproducibility evaluation of liver stiffness measurement by transient elastography. Eur. J. Gastroenterol. Hepatol. 20(7), 693-701 (2008).
13. Mederacke I, Wursthorn K, Kirschner J et al. Food intake increases liver stiffness in patients with chronic or resolved hepatitis C virus infection. Liver Int. 29(10), 1500-1506 (2009).
14. Roulot D, Czernichow S, Le Clesiau H et al. Liver stiffness values in apparently healthy subjects: influence of gender and metabolic syndrome. J. Hepatol. 48(4), 606-613 (2008).
15. Kim SU, Choi GH, Han WK et al. What are true normal liver stiffness values using FibroScan? A prospective study in healthy living liver and kidney donors in South Korea. Liver Int. 30(2), 268-274 (2010).
16. Coco B, Oliveri F, Maina AM et al. Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. J. Viral Hepat. 14(5), 360-369 (2007).
17. Arena U, Vizzutti F, Corti G et al. Acuteviral hepatitis increases liver stiffness values measured by transient elastography. Hepatology 47(2), 380-384 (2008).
18. Sagir A, Erhardt A, Schmitt M et al. Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage. Hepatology 47(2), 592-595 (2008).
19. Seo YS, Lee KG, Jung ES et al. Dynamic changes in liver stiffness during the course of acute hepatitis A. Scand J. Gastroenterol. 45(4), 501-504 (2010).
20. Kim SU, Han KH, Park JY et al. Liver stiffness measurement using FibroScan is influenced by serum total bilirubin in acute hepatitis. Liver Int. 29(6), 810-815 (2009).
21. Talwalkar JA, Kurtz DM, Schoenleber SJ et al. Ultrasound-based transient elastography for the detection of hepatic fibrosis: systematic review and metaanalysis. Clin. Gastroenterol. Hepatol. 5(10), 1214-1220 (2007).
22. Friedrich-Rust M, Ong MF, Martens S et al. Performance of transient elastography for the staging of liver fibrosis: a metaanalysis. Gastroenterology 134(4), 960-974 (2008).
23. Stebbing J, Farouk L, Panos G et al. A meta-analysis of transient elastography for the detection of hepatic fibrosis. J. Clin. Gastroenterol. 44(3), 214-219 (2010).
24. Ziol M, Handra-Luca A, Kettaneh A et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 41(1), 48-54 (2005).
25. Castera L, Vergniol J, Foucher J et al.Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 128(2), 343-350 (2005).
26. Arena U, Vizzutti F, Abraldes JG et al. Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C. Gut 57(9), 1288-1293 (2008).
27. Vispo E, Barreiro P, Del Valle J et al. Overestimation of liver fibrosis staging using transient elastography in patients with chronic hepatitis C and significant liver inflammation. Antivir. Ther. 14(2), 187-193 (2009).
28. Vergniol J, Foucher J, Castera L et al. Changes of non-invasive markers and FibroScan values during HCV treatment. J. Viral Hepat. 16(2), 132-140 (2009).
29. Ogawa E, Furusyo N, Toyoda K et al. The longitudinal quantitative assessment by transient elastography of chronic hepatitis C patients treated with pegylated interferon a-2b and ribavirin. Antiviral Res. 83(2), 127-134 (2009).
30. Vergniol J, Foucher J, Mamou K et al. Non-invasive evaluation of liver fibrosis using FibroScan in long-term sustainedvirological responder patients after HCV treatment. Gastroenterol. Clin. Biol. 32(12), 1061-1063 (2008).
31. Vergara S, Macias J, Rivero A et al. The use of transient elastometry for assessing liver fibrosis in patients with HIV and hepatitis C virus coinfection. Clin. Infect. Dis. 45(8), 969-974 (2007).
32. de Ledinghen V, Douvin C, Kettaneh A et al. Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV/hepatitis C virus-coinfected patients. J. Acquir. Immune Defic. Syndr. 41(2), 175-179 (2006).
33. Kirk GD, Astemborski J, Mehta SH et al. Assessment of liver fibrosis by transient elastography in persons with hepatitis C virus infection or HIV-hepatitis C virus coinfection. Clin. Infect. Dis. 48(7), 963-972 (2009).
34. Moreno S, Garcia-Samaniego J, Moreno A et al. Noninvasive diagnosis of liver fibrosis in patients with HIV infection and HCV/HBV co-infection. J. Viral Hepat. 16(4), 249-258 (2009).
35. Macias J, Recio E, Vispo E et al. Application of transient elastometry to differentiate mild from moderate to severe liver fibrosis in HIV/HCV co-infected patients. J. Hepatol. 49(6), 916-922 (2008).
36. Rigamonti C, Donato MF, Fraquelli M et al. Transient elastography predicts fibrosis progression in patients with recurrent hepatitis C after liver transplantation. Gut 57(6), 821-827 (2008).
37. Carrion JA, Navasa M, Bosch J et al. Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation. Liver Transpl. 12, 1791-1798 (2006).
38. Beckebaum S, Iacob S, Klein CG et al. Assessment of allograft fibrosis by transient elastography and noninvasive biomarker scoring systems in liver transplant patients. Transplantation 89(8), 983-993 (2010).
39. Masuzaki R, Yamashiki N, Sugawara Y et al. Assessment of liver stiffness in patients after living donor liver transplantation by transient elastograpy. Scand J. Gastroenterol. 44(9), 1115-1120 (2009).
40. Corradi F, Piscaglia F, Flori S et al. Assessment of liver fibrosis in transplant recipients with recurrent HCV infection: usefulness of transient elastography. Dig. Liver Dis. 41(3), 217-225 (2009).
41. Sanchez Antolin G, Garcia Pajares F, Vallecillo MA et al. FibroScan evaluation of liver fibrosis in liver transplantation. Transplant. Proc. 41(3), 1044-1046 (2009).
42. Carrion JA, Torres F, Crespo G et al. Liver stiffness identifies two different patterns of fibrosis progression in patients with hepatitis C virus recurrence after liver transplantation. Hepatology 51(1), 23-34 (2010).
43. Marcellin P, Ziol M, Bedossa P et al. Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B. Liver Int. 29(2), 242-247 (2009).
44. Chan HL, Wong GL, Choi PC et al. Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B. J. Viral Hepat. 16(1), 36-44 (2009).
45. Maimone S, Calvaruso V, Pleguezuelo M et al. An evaluation of transient elastography in the discrimination of HBeAg-negative disease from inactive hepatitis B carriers. J. Viral Hepat. 16(11), 769-774 (2009).
46. Fung J, Lai CL, Chan SC et al. Correlation of liver stiffness and histological features in healthy persons and in patients with occult hepatitis B, chronic active hepatitis B, or hepatitis B cirrhosis. Am. J. Gastroenterol. 105(5), 1116-1122 (2010).
47. Corpechot C, El Naggar A, Poujol-Robert A et al. Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC. Hepatology 43(5), 1118-1124 (2006).
48. Gomez-Dominguez E, Mendoza J, Garcia-Buey L et al. Transient elastography to assess hepatic fibrosis in primary biliary cirrhosis. Aliment Pharmacol. Ther. 27(5), 441-447 (2008).
49. Millonig G, Reimann FM, Friedrich S et al. Extrahepatic cholestasis increases live stiffness (FibroScan) irrespective of fibrsis. Hepatology 48(5), 1718-1723 (2008).
50. Laharie D, Zerbib F, Adhoute X et al. Diagnosis of liver fibrosis by transient elastography (FibroScan) and non-invasive methods in Crohns disease patients treated with methotrexate. Aliment Pharmacol. Ther. 23(11), 1621-1628 (2006).
51. Berends MA, Snoek J, de Jong EM et al. Biochemical and biophysical assessment of MTX-induced liver fibrosis in psoriasis patients: FibroTest predicts the presence and FibroScan predicts the absence of significant liver fibrosis. Liver Int. 27(5), 639-645 (2007).
52. Adhoute X, Foucher J, Laharie D et al. Diagnosis of liver fibrosis using FibroScan and other noninvasive methods in patients with hemochromatosis: a prospective study. Gastroenterol. Clin. Biol. 32(2), 180-187 (2008).
53. di Marco V, Bronte F, Cabibi D et al. Noninvasive assessment of liver fibrosis in thalassaemia major patients by transient elastography (TE) - lack of interference by iron deposition. Br. J. Haematol. 148(3), 476-479 (2009).
54. Nahon P, Kettaneh A, Tengher-Barna I et al. Assessment of liver fibrosis using transient elastography in patients with alcoholic liver disease. J. Hepatol. 49(6), 1062-1068 (2008).
55. Nguyen-Khac E, Chatelain D, Tramier B et al. Assessment of asymptomatic liver fibrosis in alcoholic patients using fibroscan: prospective comparison with seven non-invasive laboratory tests. Aliment Pharmacol. Ther. 28(10), 1188-1198 (2008).
56. Wong VW, Vergniol J, Wong GL et al. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology 51(2), 454-462 (2010).
57. Petta S, Camma C, Dim V et al. Insulin resistance is a major determinant of liver stiffness in nondiabetic patients with HCV genotype 1 chronic hepatitis. Aliment Pharmacol. Ther. 30(6), 603-613 (2009).
58. Merchante N, Rivero A, de Los Santos- Gil I et al. Insulin resistance is associated with liver stiffness in HIV/HCV coinfected patients. Gut 58(12), 1654-1660 (2009).
59. de Ledinghen V, Vergniol J, Foucher J et al. Feasibility of liver transient elastography with FibroScan® using a new probe for obese patients. Liver Intern. 30(7), 1043-1048 (2010).
60. De Ledinghen V, Le Bail B, Rebouissoux L et al. Liver stiffness measurement in children using FibroScan: feasibility study and comparison with Fibrotest, aspartate transaminase to platelets ratio index, and liver biopsy. J. Pediatr. Gastroenterol. Nutr. 45(4), 443-450 (2007).
61. Nobili V, Vizzutti F, Arena U et al. Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis. Hepatology 48, 442-448 (2008).
62. Witters P, de Boeck K, Dupont L et al. Non-invasive liver elastography (Fibroscan) for detection of cystic fibrosis-associated liver disease. J. Cyst. Fibros. 8(6), 392-399 (2009).
63. Menten R, Leonard A, Clapuyt P et al. Transient elastography in patients with cystic fibrosis. Pediatr. Radiol. 40(7), 1231-1235 (2010).
64. Foucher J, Chanteloup E, Vergniol J et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 55(3), 403-408 (2006).
65. Kazemi F, Kettaneh A, Nkontchou G et al. Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices. J. Hepatol. 45, 230-235 (2006).
66. Vizzutti F, Arena U, Romanelli RG et al. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology 45(5), 1290-1297 (2007).
67. Bureau C, Metivier S, Peron JM et al. Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease. Aliment Pharmacol. Ther. 27(12), 1261-1268 (2008).
68. Castera L, le Bail B, Roudot-Thoraval F et al. Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores. J. Hepatol. 50(1), 59-68 (2009).
69. Masuzaki R, Tateishi R, Yoshida H et al. Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography. Hepatology 49(6), 1954-1961 (2009).
70. Wong GL, Wong VW, Choi PC et al. Assessment of fibrosis by transient elastography compared with liver biopsy and morphometry in chronic liver diseases. Clin. Gastroenterol. Hepatol. 6(9), 1027-1035 (2008).
71. Millonig G, Friedrich S, Adolf S et al. Liver stiffness is directly influenced by central venous pressure. J. Hepatol. 52(2), 206-210 (2010).
72. Friedrich-Rust M, Wunder K, Kriener S et al. Liver fibrosis in viral hepatitis: noninvasive assessment with acoustic radiation force impulse imaging versus transient elastography. Radiology 252(2), 595-604 (2009).
73. Takahashi H, Ono N, Eguchi Y et al. Evaluation of acoustic radiation force impulse elastography for fibrosis staging of chronic liver disease: a pilot study. Liver Int. 30(4), 538-545 (2010).
74. Foucher J, Reiller B, Jullien V et al. FibroScan used in street-based outreach for drug users is useful for hepatitis C virus screening and management: a prospective study. J. Viral Hepat. 16(2), 121-131 (2009).
75. Ganne-Carrie N, Ziol M, de Ledinghen V et al. Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology 44(6), 1511-1517 (2006).
76. Poynard T, Halfon P, Castera L et al. Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stages. Clin. Chem. 53(9), 1615-1622 (2007).
77. Gomez-Dominguez E, Mendoza J, Rubio S et al. Transient elastography: a valid alternative to biopsy in patients with chronic liver disease. Aliment Pharmacol. Ther. 24(3), 513-518 (2006).